. Author manuscript; available in PMC: 2017 Nov 7.

Published in final edited form as: Am J Cardiol. 2017 Jul 24;120(8):1293–1297. doi: 10.1016/j.amjcard.2017.07.012

Table 3.

Adjusted odds for outcomes (primary analysis). Statistical significance for categorical variables tested using Pearson test and Deuchler-Wilcoxon procedure for continuous variables

Outcome	β-blocker
Outcome	Adjusted OR (95% CI)
Delirium incidence	0.95 (0.79 to 1.15)
Delirium duration	0.72 (0.52 to 0.96)^*
Kidney Disease: Improving Global Outcome
Stage 1	1.07 (0.87 to 1.30)
Stage 2	1.96 (1.19 to 3.24)^†
Stage 3	1.22 (0.56 to 2.60)
Atrial fibrillation	1.13 (0.95 to 1.34)
Mortality
90 days	1.20 (0.71 to 2.03)
1-year	1.10 (0.73 to 1.65)
Length of stay (Δdays)	−0.11 (−0.51 to 0.28)
Stroke^‡	0.88

OR = odds ratio; CI = confidence interval.

p < 0.05.

^†

p < 0.01.

^‡

Fisher test used to determine statistical significance.